A simple and rapid diagnostic method for 13 types of high-risk human papillomavirus (HR-HPV) detection using CRISPR-Cas12a technology
Abstract Cervical carcinoma is the second most common cancer in women worldwide with greater than 99% of the cases caused by human papillomaviruses (HPVs). Early detection of HPVs especially the high risk types (HR-HPVs) are essential to prevent the disease progression. The existing methods for HPV...
Guardado en:
Autores principales: | Jiaojiao Gong, Guanghui Zhang, Wangguo Wang, Liping Liang, Qianyun Li, Menghao Liu, Liang Xue, Guanghui Tang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/187295dff3134ec8935b1df1dfef0400 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Abbott Alinity m HR-HPV, a novel human papillomavirus assay for primary cervical cancer screening, is adapted to HPV guidelines
por: Lina Mouna, et al.
Publicado: (2021) -
CRISPR/Cas-based Diagnostics and Gene Therapy
por: Meiyu Qiu, et al.
Publicado: (2021) -
Amplification-free RNA detection with CRISPR–Cas13
por: Hajime Shinoda, et al.
Publicado: (2021) -
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time
por: Kayla G. Barnes, et al.
Publicado: (2020) -
Definition of CRISPR Cas12a Trans-Cleavage Units to Facilitate CRISPR Diagnostics
por: Hailong Lv, et al.
Publicado: (2021)